Showing results (61-70 of 70) with videos related to
Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 70 results.
Modern Rheumatology|December 8, 2022
Nation-wide cohort study of remission induction therapy using rituximab in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis: Effectiveness and safety in the first 6 monthsKenji Nagasaka, Koichi Amano, Hiroaki Dobashi, et al.Rheumatology (Oxford, England)|January 18, 2020
Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT studyYoshikazu Nakaoka, Mitsuaki Isobe, Yoshiya Tanaka, et al.Pathology, Research and Practice|March 20, 2025
Artificial intelligence challenge of discriminating cutaneous arteritis and polyarteritis nodosa based on hematoxylin-and-eosin images of skin biopsy specimensWataru Kashiwa, Kenji Hirata, Hiroki Endo, et al.Therapeutic Advances in Musculoskeletal Disease|February 26, 2026
Three-drug combination therapy to prevent glucocorticoid-associated osteonecrosis in patients with systemic lupus erythematosus: a proof-of-concept studyGoro Motomura, Yojiro Arinobu, Hiroaki Niiro, et al.Modern Rheumatology|August 8, 2024
Pregnancy and childbirth in Takayasu arteritis in Japan: A nationwide retrospective studyTakako Miyamae, Yusuke Manabe, Takahiko Sugihara, et al.Drug Discoveries & Therapeutics|April 26, 2026
Efficacy and safety of filgotinib versus tocilizumab in active rheumatoid arthritis: A randomized, open-label, multicenter study with clinical and musculoskeletal ultrasound evaluation (TRANSFORM study)Toshimasa Shimizu, Shin-Ya Kawashiri, Tomohiro Koga, et al.RMD Open|February 27, 2023
Prevalence and risk factors of osteonecrosis of the femoral head in patients with ANCA-associated vasculitis: a multicentre cohort studyNorihiro Mimura, Taro Iwamoto, Shunsuke Furuta, et al.Arthritis & Rheumatology (Hoboken, N.J.)|February 12, 2024
Clinical Characteristics and Outcomes of Polyarteritis Nodosa: An International StudyOmer Karadag, Ertugrul Cagri Bolek, Gizem Ayan, et al.Annals of the Rheumatic Diseases|March 23, 2023
Rituximab versus azathioprine for maintenance of remission for patients with ANCA-associated vasculitis and relapsing disease: an international randomised controlled trialRona M Smith, Rachel B Jones, Ulrich Specks, et al.Annals of the Rheumatic Diseases|June 26, 2020
Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitisRona M Smith, Rachel Bronwen Jones, Ulrich Specks, et al.Pageof 7